Prescription medication exchange patterns among methadone maintenance patients

Drug and Alcohol Dependence

Volumn 127, Issue 1-3, 2013, Pages 232-238

  Caviness, Celeste M ^a   Anderson, Bradley J ^a   de Dios, Marcel A ^a,b   Kurth, Megan ^a   Stein, Michael ^a,b  

^a BUTLER HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Diversion; Methadone; Prescription medication

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; BUPRENORPHINE PLUS NALOXONE; COCAINE; DIAMORPHINE; METHADONE; MOOD STABILIZER; SEDATIVE AGENT;

ADULT; AGE; ARTICLE; CLINICAL TRIAL (TOPIC); COCAINE DEPENDENCE; DEMOGRAPHY; DRUG ABUSE; FEMALE; HEROIN DEPENDENCE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; METHADONE TREATMENT; NORMAL HUMAN; PRESCRIPTION; PRESCRIPTION MEDICATION EXCHANGE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; SMOKING; SMOKING CESSATION; SOCIAL STATUS;

ADULT; COHORT STUDIES; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; YOUNG ADULT;

EID: 84870942506     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.07.007     Document Type: Article

References (50)

1. Agresti A. Categorical Data Analysis 2002, Wiley-Interscience, Hoboken, NJ. 2nd ed.
2. Arria A.M., Caldeira K.M., O'Grady K.E., Vincent K.B., Fitzelle D.B., Johnson E.P., Wish E.D. Drug exposure opportunities and use patterns among college students: results of a longitudinal prospective cohort study. Subst. Abuse 2008, 29:19-38.
3. Bazazi A.R., Yokell M., Fu J.J., Rich J.D., Zaller N.D. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. J. Addict. Med. 2011, 5:175-180.
4. Best D., Lehmann P., Gossop M., Harris J., Noble A., Strang J. Eating too little, smoking and drinking too much: wider lifestyle problems among methadone maintenance patients. Addict. Res. Theory 1998, 6:489-498.
5. Buis, M., 2007. SEQLOGIT: Stata Module to Fit a Sequential Logit Model. http://ideas.repec.org/c/boc/bocode/s456843.html.
6. Centers for Disease Control and Prevention, 2011a. Policy Impact: Prescription Painkilller Overdoses. Atlanda, GA.
7. Centers for Disease Control and Prevention Vital Signs: Overdoses of Prescription Opioid Pain Relievers - United States, 1999-2008. MMWR 2011, 60:1487-1492.
8. Clarke J.G., Stein M.D., McGarry K.A., Gogineni A. Interest in smoking cessation among injection drug users. Am. J. Addict. 2001, 10:159-166.
9. Cullen W., O'Brien S., O'Carroll A., O'Kelly F.D., Bury G. Chronic illness and multimorbidity among problem drug users: a comparative cross sectional pilot study in primary care. BMC Fam. Pract. 2009, 10:25.
10. De Maeyer J., Vanderplasschen W., Lammertyn J., van Nieuwenhuizen C., Sabbe B., Broekaert E. Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment. Qual. Life Res. 2011, 20:139-150.
11. Demarie D., Marletta G., Imazio M., Cappa C., Ferro S., Compostino R., De Vivo E., Trinchero R., Bignamini E. Cardiovascular-associated disease in an addicted population: an observation study. J. Cardiovasc. Med. (Hagerstown) 2011, 12:51-54.
12. Ellis J., Mullan J. Prescription medication borrowing and sharing - risk factors and management. Aust. Fam. Physician 2009, 38:816-819.
13. Ellis J.C., Mullan J., Worsley T. Prescription medication hoarding and borrowing or sharing behaviours in older residents in the Illawarra, New South Wales, Australia. Australas. J. Ageing 2011, 30:119-123.
14. Fareed A., Casarella J., Amar R., Vayalapalli S., Drexler K. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. J. Psychiatr. Pract. 2009, 15:227-234.
15. Fischer B., Bibby M., Bouchard M. The global diversion of pharmaceutical drugsnon-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures. Addiction 2010, 105:2062-2070.
16. Ford J.A., Lacerenza C. The relationship between source of diversion and prescription drug misuse, abuse, and dependence. Subst. Use Misuse 2011, 46:819-827.
17. Frauger E., Nordmann S., Orleans V., Pradel V., Pauly V., Thirion X., Micallef J. Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey. Fundam. Clin. Pharmacol. 2011, (ePub.).
18. Garnier L.M., Arria A.M., Caldeira K.M., Vincent K.B., O'Grady K.E., Wish E.D. Sharing and selling of prescription medications in a college student sample. J. Clin. Psychiatry 2010, 71:262-269.
19. Goebel J.R., Compton P., Zubkoff L., Lanto A., Asch S.M., Sherbourne C.D., Shugarman L., Lorenz K.A. Prescription sharing, alcohol use, and street drug use to manage pain among veterans. J. Pain Symptom Manage. 2011, 41:848-858.
20. Goldsworthy R.C., Schwartz N.C., Mayhorn C.B. Beyond abuse and exposure: framing the impact of prescription-medication sharing. Am. J. Public Health 2008, 98:1115-1121.
21. Gwin Mitchell S., Kelly S.M., Brown B.S., Schacht Reisinger H., Peterson J.A., Ruhf A., Agar M.H., O'Grady K.E., Schwartz R.P. Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. Am. J. Addict. 2009, 18:346-355.
22. Hartung D.M., Carlson M.J., Kraemer D.F., Haxby D.G., Ketchum K.L., Greenlick M.R. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population. Med. Care 2008, 46:565-572.
23. Inciardi J.A., Surratt H.L., Cicero T.J., Kurtz S.P., Martin S.S., Parrino M.W. The black box of prescription drug diversion. J. Addict. Dis. 2009, 28:332-347.
24. Inciardi J.A., Surratt H.L., Kurtz S.P., Cicero T.J. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007, 8:171-183.
25. Kandel D.B., Huang F.Y., Davies M. Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend. 2001, 64:233-241.
26. Lofwall M.R., Brooner R.K., Bigelow G.E., Kindbom K., Strain E.C. Characteristics of older opioid maintenance patients. J. Subst. Abuse Treat. 2005, 28:265-272.
27. Maddala G. Limited Dependent and Qualitative Variables in Econometrics 1983, Cambridge University Press, Cambridge.
28. Mare R. Change and stability in educational stratification. Am. Sociol. Rev. 1981, 46:72-87.
29. McCabe S.E., Cranford J.A., Boyd C.J., Teter C.J. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict. Behav. 2007, 32:562-575.
30. McCabe S.E., Teter C.J., Boyd C.J. Medical use, illicit use and diversion of prescription stimulant medication. J. Psychoactive Drugs 2006, 38:43-56.
31. McCabe S.E., Teter C.J., Boyd C.J. Medical use, illicit use, and diversion of abusable prescription drugs. J. Am. Coll. Health 2006, 54:269-278.
32. McCabe S.E., West B.T., Teter C.J., Ross-Durow P., Young A., Boyd C.J. Characteristics associated with the diversion of controlled medications among adolescents. Drug Alcohol Depend. 2011, 118:452-458.
33. McCauley J.L., Amstadter A.B., Macdonald A., Danielson C.K., Ruggiero K.J., Resnick H.S., Kilpatrick D.G. Non-medical use of prescription drugs in a national sample of college women. Addict. Behav. 2011, 36:690-695.
34. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 1992, 9:199-213.
35. Mendelson J., Flower K., Pletcher M.J., Galloway G.P. Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine. Exp. Clin. Psychopharmacol. 2008, 16:435-441.
36. Mertens J.R., Lu Y.W., Parthasarathy S., Moore C., Weisner C.M. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch. Intern. Med. 2003, 163:2511-2517.
37. Mitchell S.G., Kelly S.M., Gryczynski J., Myers C.P., Jaffe J.H., O'Grady K.E., Olsen Y.K., Schwartz R.P. African American patients seeking treatment in the public sector: characteristics of buprenorphine vs. methadone patients. Drug Alcohol Depend. 2011, 122:55-60.
38. National Institute on Drug Abuse Research Report Series: Prescription Drugs: Abuse and Addiction 2011, NIH Publication Number 11-4881, Bethesda, MD.
39. National Institute on Drug Abuse Topics in Brief: Prescription Drug Abuse December 2011, National Institutes of Health; Department of Health and Human Services, Bethesda, MD.
40. Petersen E.E., Rasmussen S.A., Daniel K.L., Yazdy M.M., Honein M.A. Prescription medication borrowing and sharing among women of reproductive age. J. Womens Health (Larchmt.) 2008, 17:1073-1080.
41. Rounsaville B.J., Weissman M.M., Crits-Christoph K., Wilber C., Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Arch. Gen. Psychiatry 1982, 39:151-156.
42. Sharkey K.M., Kurth M.E., Anderson B.J., Corso R.P., Millman R.P., Stein M.D. Assessing sleep in opioid dependence: a comparison of subjective ratings, sleep diaries, and home polysomnography in methadone maintenance patients. Drug Alcohol Depend. 2011, 113:245-248.
43. StataCorp, 2008. Stata Statistical Software: Release 10.1. StataCorp LP, College Station, TX.
44. Stein M.D., Herman D.S., Bishop S., Lassor J.A., Weinstock M., Anthony J., Anderson B.J. Sleep disturbances among methadone maintained patients. J. Subst. Abuse Treat. 2004, 26:175-180.
45. Substance Abuse and Mental Health Services Administration; Center for Behavioral Health Statistics and Quality, December 28, 2010. The DAWN Report: Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD.
46. Substance Abuse and Mental Health Services Administration; Center for Behavioral Health Statistics and Quality, November 25, 2010. The DAWN Report: Drug-Related Emergency Department Visits Involving Pharmaceutical Misuse and Abuse by Older Adults. Rockville, MD.
47. Teichtahl H., Wang D., Cunnington D., Kronborg I., Goodman C., Prodromidis A., Drummer O. Cardiorespiratory function in stable methadone maintenance treatment (MMT) patients. Addict. Biol. 2004, 9:247-253.
48. U.S. Drug Enforcement Administration; Office of Diversion Control, Inside Diversion Control: Program Description. Available from: (accessed 27.02.12). http://www.deadiversion.usdoj.gov/prog_dscrpt/index.html.
49. West J.C., Wilk J.E., Rae D.S., Muszynski I.S., Stipec M.R., Alter C.L., Sanders K.E., Crystal S., Regier D.A. Medicaid prescription drug policies and medication access and continuity: findings from ten states. Psychiatr. Serv. 2009, 60:601-610.
50. Wilens T.E., Adler L.A., Adams J., Sgambati S., Rotrosen J., Sawtelle R., Utzinger L., Fusillo S. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47:21-31.